Formulation of Metformin-Loaded Chitosan Nanoparticles and In Vivo Evaluation of Its Hypoglycemic Effects
Molecules · 06.05.2026 · 31 (9) · 1539
DOI: 10.3390/molecules31091539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 06.05.2026. Verfasst von Zainab Omeed Awchee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Cyprus International University, Nicosia 99258, Cyprus. Hauptthemen laut MEDLINE: Metformin, Chitosan, Hypoglycemic Agents, Nanoparticles. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study formulated and characterized metformin-loaded chitosan nanoparticles (NPs) using the ionic gelation technique and evaluated the drug release kinetics. Characterization confirmed successful drug encapsulation, with Fourier-transform infrared spectroscopy (FTIR) indicating compatibility, and X-ray diffraction (XRD) showing attenuation of characteristic metformin reflections consistent with reduced crystalline contribution after encapsulation. Particle sizes ranged from 74.28 to 86.82 nm. The NPs exhibited stable zeta potentials (+42.38 to +49.06 mV) and high entrapment efficiencies (68.42–81.26%). In vitro drug release studies at pH 7.4 and pH 2.0 demonstrated an initial burst release, followed by sustained release over 24 h. The cumulative drug release ranged from 81.92% to 97.72% at pH 7.4 and 89.4% to 98.1% at pH 2.0, with a faster release at pH 2.0. Drug release kinetics followed first-order for batch MN1, while batches MN2 and MN3 best fitted into the Higuchi model, indicating diffusion-controlled release through the chitosan polymeric network. The formulated metformin nanoparticles demonstrated significant potent dose-related and time-dependent cytotoxic effect against ovarian cancer cell lines and in vivo blood glucose lowering effect compared to the conventional dosage forms and control (p < 0.05). These findings highlight the potential of metformin-loaded chitosan NPs for sustained drug delivery, which may enhance patient compliance by reducing dosing frequency. Future studies should further explore their clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Cyprus International University, Nicosia 99258, Cyprus.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jadara University, Irbid 21110, Jordan.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Institute of Graduate Studies and Research, Eastern Mediterranean University, Famagusta 99628, Cyprus.
ORCID-Profile: Airemwen Collins Ovenseri, Ahmad Saleh Malkawi, Leyla Beba Pozharani
Zitieren
APA
Awchee, Z. O., Ovenseri, A. C., Malkawi, A. S., & Pozharani, L. B. (2026). Formulation of Metformin-Loaded Chitosan Nanoparticles and In Vivo Evaluation of Its Hypoglycemic Effects. Molecules, 31(9), 1539. https://doi.org/10.3390/molecules31091539
Vancouver
Awchee ZO, Ovenseri AC, Malkawi AS, Pozharani LB. Formulation of Metformin-Loaded Chitosan Nanoparticles and In Vivo Evaluation of Its Hypoglycemic Effects. Molecules. 2026;31(9):1539. doi:10.3390/molecules31091539
BibTeX
@article{Awchee2026,
author = {Awchee, Zainab Omeed and Ovenseri, Airemwen Collins and Malkawi, Ahmad Saleh and Pozharani, Leyla Beba},
title = {Formulation of Metformin-Loaded Chitosan Nanoparticles and In Vivo Evaluation of Its Hypoglycemic Effects},
journal = {Molecules},
year = {2026},
volume = {31},
number = {9},
pages = {1539},
doi = {10.3390/molecules31091539}
}
EUVIMED